Figure 7
(A) Protein crystallographic structural model of human NR3C1 (PDB ID: 1ZXM) with the co-crystallized inhibitor CV7 binding site (orange color sphere). (B) Binding site pocket residues with best fit confirmation of maslinic acid analog P-902 (yellow color). (C) Binding site pocket residues with docked maslinic acid analog P-902 (green color) and control drug CV7.
